Hedge Fund - Roumell Asset Management

In relation to DSP Group, Inc. (NASDAQ:DSPG), Roumell reported an increase in its ownership, to a current amount of 1.06 million shares, from 984,200 shares declared in its last 13F filing.

Jim Roumell’s Roumell Asset Management dumped its shares in QAD Inc. (NASDAQ:QADA) and Dover Motorsports, Inc.(NYSE:DVD).

Jim Roumell's fund Roumell Asset Management, has disclosed, in a newly amended filing, that it has sent a letter to the board of directors of Transcept Pharmaceuticals Inc (NASDAQ:TSPT), in which it...

Roumell Asset Management, run by Jim Roumell, is reducing its exposure to Transcept Pharmaceuticals Inc (NASDAQ:TSPT).

Roumell Asset Management, led by Jim Roumell, disclosed, in a new filing with the Securities and Exchange Commission, a letter sent to the board of Transcept Pharmaceuticals Inc (NASDAQ:TSPT).

Roumell Asset Management, led by Jim Roumell, continues selling shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT).

Jim Roumell's hedge fund, Roumell Asset Management, in a new form 4 filed with the SEC, reported selling some shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT).

Jim Roumell's Roumell Asset Management reported reducing its position in Transcept Pharmaceuticals Inc (NASDAQ:TSPT) to some 2.3 million shares.

Transcept Pharmaceuticals news: Transcept Pharmaceuticals Inc (NASDAQ:TSPT) is a small-cap stock that recently was cut slightly in the equity portfolio of Roumell Asset Management, a hedge fund managed...